USP1 driven mitotic dysregulation and PLK1 stabilization confer Lenvatinib resistance in hepatocellular carcinoma.
USP1 驱动的有丝分裂失调和 PLK1 稳定赋予肝细胞癌 Lenvatinib 耐药性。
期刊:Journal of Experimental & Clinical Cancer Research
影响因子:12.8
doi:10.1186/s13046-026-03683-w
Qiang Yuwei, Bian Saiyan, Tong Yun, Chen Weiting, Tang Zhangzhi, Dai Chengchen, Liu Mingyu, Xu Banglong, Jiang Lihan, Ma Kexin, He Xuyang, Li Jinlong, Xiao Mingbing, Zheng Wenjie